RxWIRE Newsletter
Home
»
Blog
Allegiant Rx Blog
12-22-2016
RxWIRE Newsletter – December 22, 2016
We won't surprise anyone by saying that Topic No. 1 in pharma this year was drug pricing. We'll give you one guess as to whether 2017 will be more of the same.
Read More
12-15-2016
RxWIRE Newsletter – December 15, 2016
The financial future of pharmacy benefit managers is uncertain as payers, legislators and regulators focus on rising drug prices, according to Moody's Investors Service.
Read More
12-08-2016
RxWIRE Newsletter – December 8, 2016
That didn't take long. Less than a week since Allergan CEO Brent Saunders implored pharma to take the initiative to defuse a public debate on drug pricing, Novo Nordisk has become the second player to make a cost pledge.
Read More
12-01-2016
RxWIRE Newsletter – December 1, 2016
The House plans to vote Wednesday on a $6.3 billion bill aimed at speeding federal approval of drugs and medical devices and boosting biomedical research.
Read More
